Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Edgeline Holdings has signed a joint development agreement with Houston Pharmaceuticals to assist the company in obtaining a license for certain patents, several of which are from the University of Mississippi and the University of Louisiana.
Subscribe to our email newsletter
Houston Pharmaceuticals will continue collaborations with both universities and assist in securing grants on behalf of the company.
Leonard Ivins, CEO of Edgeline Holdings, said: “Houston Pharmaceuticals will be instrumental in assisting us through the stage of evaluating and licensing these patents and we believe this relationship will add depth to our company, both in name recognition and industry experience.”